A phase II study of Su011248 [sunitinib] in patients with recurrent and/or metastatic squamous head and neck carcinoma.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2016
At a glance
- Drugs Sunitinib (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 27 Jun 2012 Last checked against European Clinical Trials Database record.
- 09 Mar 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.